Glaukos (GKOS) Preferred Stock Liabilities (2013 - 2014)
Glaukos (GKOS) reported Preferred Stock Liabilities of $157.4 million for Q4 2014, up 0.75% year-over-year from $156.2 million in Q4 2013, and up 0.75% quarter-over-quarter from $156.2 million in Q4 2013.
Glaukos (GKOS) Preferred Stock Liabilities (2013 - 2014) Analysis & Trends
Glaukos (GKOS) has 2 years of Preferred Stock Liabilities data on file, last reported at $157.4 million in Q4 2014.
- Preferred Stock Liabilities for Q4 2014 came in at $157.4 million, up 0.75% year-over-year; the trailing twelve-month figure through Dec 2014 was $157.4 million (up 0.75% YoY), and the FY2014 annual result was $157.4 million, up 0.75% from the prior year.
- Preferred Stock Liabilities rose to $157.4 million in Q4 2014 per GKOS's latest filing, from $156.2 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $157.4 million in Q4 2014 and troughed at $156.2 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Glaukos | 7.55 Bn | 7.45 Bn | 117.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 157.38 Mn |
| Dec 31, 2013 | 156.21 Mn |